Racial disparities in the survival of patients with indolent non‐Hodgkin lymphomas in the United States
Vaughn J, Spies D, Xavier A, Epperla N. Racial disparities in the survival of patients with indolent non‐Hodgkin lymphomas in the United States. American Journal Of Hematology 2021, 96: 816-822. PMID: 33864695, DOI: 10.1002/ajh.26198.Peer-Reviewed Original ResearchConceptsIndolent non-Hodgkin lymphomaSurvival of patientsHighest excess mortality ratesYoung black patientsBlack patientsNon-Hodgkin lymphomaExcess mortality ratesRelative survivalWhite patientsRacial disparitiesMortality rateExcess deathsLymphoplasmacytic lymphoma/Waldenström macroglobulinemiaFlexible parametric survival modelsAmerican Indians/Alaska NativesMarginal zone lymphomaAsian/Pacific IslandersSignificant racial differencesPaucity of dataAdult patientsDisease histologyPrimary outcomeParametric survival modelsMultivariable analysisWaldenström's macroglobulinemiaSurvival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017)
Vaughn J, Pinheiro L, Olszewski A, Epperla N. Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017). American Journal Of Hematology 2021, 96: e123-e126. PMID: 33476433, DOI: 10.1002/ajh.26103.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesConfounding Factors, EpidemiologicFemaleHumansKaplan-Meier EstimateLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedMortalityPrognosisRituximabSEER ProgramSocial Determinants of HealthUnited StatesYoung AdultConceptsPopulation-based cohort studySurvival of patientsMarginal zone lymphomaCohort studyPatientsLymphoma